A study published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University shows how common ...

Researchers have found that gut bacteria can interfere with the effectiveness of over 400 commonly used medications that ...

Common gut bacteria can metabolise some oral medications potentially rendering these important drugs against migraines, dep ...

A new study, published today in Nature Chemistry by researchers from the University of Pittsburgh and Yale University , shows how common gut ...

Common gut bacteria may interfere with the effectiveness of widely used medications for conditions such as migraines, depression, type 2 diabetes, and prostate cancer, a new study has revealed.

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

Both ibuprofen and naproxen potently inhibit hTAS1R2–TAS1R3 receptors that sense sweetness in a dose-dependent manner. The ...

American Century Companies Inc. increased its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Structure Therapeutics Inc.’s GPCR share price has dipped by 12.27%, which has investors questioning if this is right time to buy.

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) has been given an average rating of “Buy” by the eight research ...